Ethyl pyruvate administration suppresses growth and invasion of gallbladder cancer cells via downregulation of HMGB1-RAGE axis.
about
Ethyl pyruvate is a novel anti-inflammatory agent to treat multiple inflammatory organ injuriesHMGB1 targeting by ethyl pyruvate suppresses malignant phenotype of human mesothelioma.Prognostic significance of nuclear hepatoma-derived growth factor expression in gallbladder cancerDownregulated expression of hepatoma-derived growth factor (HDGF) reduces gallbladder cancer cell proliferation and invasion.The Role of Glyoxalase-I (Glo-I), Advanced Glycation Endproducts (AGEs), and Their Receptor (RAGE) in Chronic Liver Disease and Hepatocellular Carcinoma (HCC).Delineating the HMGB1 and HMGB2 interactome in prostate and ovary epithelial cells and its relationship with cancer.
P2860
Ethyl pyruvate administration suppresses growth and invasion of gallbladder cancer cells via downregulation of HMGB1-RAGE axis.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Ethyl pyruvate administration ...... regulation of HMGB1-RAGE axis.
@en
Ethyl pyruvate administration ...... regulation of HMGB1-RAGE axis.
@nl
type
label
Ethyl pyruvate administration ...... regulation of HMGB1-RAGE axis.
@en
Ethyl pyruvate administration ...... regulation of HMGB1-RAGE axis.
@nl
prefLabel
Ethyl pyruvate administration ...... regulation of HMGB1-RAGE axis.
@en
Ethyl pyruvate administration ...... regulation of HMGB1-RAGE axis.
@nl
P2093
P2860
P1476
Ethyl pyruvate administration ...... regulation of HMGB1-RAGE axis.
@en
P2093
P2860
P304
P356
10.1177/039463201202500413
P577
2012-10-01T00:00:00Z